HPQ
21
-2
CI
50
-5
JNJ
69
-3
HRL
32
-3
GS
72
-3
CCL
64
-3
WFC
50
-2
EMC
67
-2
STZ
48
-4
WAT
53
-4
BWA
59
-2
AVGO
45
5
MCD
44
-3
HCA
60
-8
INTU
36
-4
PWR
70
4
LB
37
2
MCK
71
-2
CPB
34
-3
ADM
68
-6
HPQ
21
-2
CI
50
-5
JNJ
69
-3
HRL
32
-3
GS
72
-3
CCL
64
-3
WFC
50
-2
EMC
67
-2
STZ
48
-4
WAT
53
-4
BWA
59
-2
AVGO
45
5
MCD
44
-3
HCA
60
-8
INTU
36
-4
PWR
70
4
LB
37
2
MCK
71
-2
CPB
34
-3
ADM
68
-6
Financhill
Back

Vistagen Therapeutics, Inc. Stock Predictions

Meet America's Newest $1B Unicorn

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
19

VTGN
Vistagen Therapeutics, Inc.

Last Price:
$0.67
Seasonality Move:
-11.81%

7 Day Trial

ALL ACCESS PASS

$ 7

The Next Gold Rush

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at

Vistagen Therapeutics, Inc. Stock Forecast

  • Is Vistagen Therapeutics, Inc. Stock Undervalued?
    The current Vistagen Therapeutics, Inc. [VTGN] share price is $0.66. The Score for VTGN is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • VTGN is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Vistagen Therapeutics, Inc. Stock Go Up Next Year?

Data Unavailable

Vistagen Therapeutics, Inc. Stock Rating

Data Unavailable

Vistagen Therapeutics, Inc. Stock Price History

Is VTGN stock going to rise?

  • The current trend is moderately bullish and VTGN is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vistagen.com

52-Week Data

52-Week High:
5.14
52-Week Low:
0.63

Prediction Charts

Market Cap:
26.2M
Price in USD:
0.66
Volume:
1.2M
Beta:
-0.37

Technical Analysis

SMA50:
2.85
SMA100:
3.25
SMA200:
2.85
52-Wk Change:
-77.27%

Stock Predictions

  • Is Vistagen Therapeutics, Inc. stock public?
    Yes, Vistagen Therapeutics, Inc. is a publicly traded company.
  • What is the Vistagen Therapeutics, Inc. stock quote today?
    The Vistagen Therapeutics, Inc. stock price is 0.66 USD today.
  • How to buy Vistagen Therapeutics, Inc. stock online?
    You can buy Vistagen Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-26 0.72 0.73 0.75 0.68
Dec-29 0.73 0.66 0.73 0.65
Dec-30 0.66 0.68 0.69 0.66
Dec-31 0.67 0.66 0.71 0.63
Jan-5 0.69 0.72 0.73 0.68
Jan-6 0.73 0.72 0.74 0.69
Jan-7 0.73 0.74 0.77 0.72
Jan-8 0.74 0.70 0.75 0.70
Jan-9 0.71 0.66 0.71 0.66
Jan-12 0.68 0.70 0.72 0.66
Jan-13 0.71 0.69 0.71 0.67
Jan-14 0.67 0.70 0.74 0.67
Jan-15 0.71 0.67 0.71 0.67
Jan-16 0.68 0.66 0.69 0.66

Vistagen Therapeutics, Inc. Earnings

Data Unavailable

Vistagen Therapeutics, Inc. Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.60 per share.

* Vistagen Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.